Who owns MAIA Biotechnology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MAIA from SEC Form 13F filings across 36 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 36 institutions disclosed 13.5M shares of MAIA Biotechnology, Inc. worth $19.4M — about 22.2% of shares outstanding; the largest disclosed holder is Solas Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
36
13F holders
$19.4M
value, 2026 filers
22.2%
of shares outstanding (13.5M sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MAIA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Solas Capital Management, LLC | 3.0M | $4.4M | 2.3% | 5% | -29.5% |
| 2 | Alyeska Investment Group, L.P. | 2.5M | $3.6M | 0.0% | 4.1% | 0.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | $3.5M | 0.0% | 4% | +16.4% |
| 4 | 683 Capital Management, LLC | 1.1M | $1.5M | 0.1% | 1.8% | 0.0% |
| 5 | Centric Wealth Management | 796,723 | $1.1M | 0.2% | 1.3% | 0.0% |
| 6 | Cable Car Capital, LP | 514,583 | $741,000 | 0.0% | 0.8% | -20.7% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 504,380 | $726,568 | 0.0% | 0.8% | +39.9% |
| 8 | Bleichroeder LP | 500,000 | $720,000 | 0.1% | 0.8% | 0.0% |
| 9 | RENAISSANCE TECHNOLOGIES LLCNEW | 415,700 | $598,608 | 0.0% | 0.7% | new |
| 10 | BlackRock, Inc. | 403,011 | $580,335 | 0.0% | 0.7% | +214.9% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 336,688 | $484,831 | 0.0% | 0.6% | +68.9% |
| 12 | STATE STREET CORP | 201,750 | $290,520 | 0.0% | 0.3% | +45.2% |
| 13 | Bleakley Financial Group, LLCNEW | 181,623 | $261,537 | 0.0% | 0.3% | new |
| 14 | NORTHERN TRUST CORP | 125,171 | $180,246 | 0.0% | 0.2% | +138.2% |
| 15 | MORGAN STANLEY | 104,017 | $149,784 | 0.0% | 0.2% | +650.5% |
| 16 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 76,000 | $109,440 | 0.0% | 0.1% | +111.1% |
| 17 | TWO SIGMA INVESTMENTS, LPNEW | 50,383 | $72,552 | 0.0% | 0.1% | new |
| 18 | ENVESTNET ASSET MANAGEMENT INCNEW | 44,347 | $63,860 | 0.0% | 0.1% | new |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 35,223 | $50,721 | 0.0% | 0.1% | new |
| 20 | PVG ASSET MANAGEMENT CORPNEW | 34,135 | $49,154 | 0.0% | 0.1% | new |
| 21 | UBS Group AG | 33,435 | $48,147 | 0.0% | 0.1% | -35.6% |
| 22 | CITADEL ADVISORS LLCNEW | 24,890 | $35,842 | 0.0% | 0% | new |
| 23 | Cetera Investment AdvisersNEW | 22,748 | $32,757 | 0.0% | 0% | new |
| 24 | LAZARI CAPITAL MANAGEMENT, INC.NEW | 21,750 | $31,320 | 0.0% | 0% | new |
| 25 | Atria Investments, IncNEW | 21,100 | $30,384 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.